Search clinical trials for: Augmenting: Antidepressant Bupropion-SR

Total 68 results

VA Office of Research and Development

Completed

VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)

Major Depressive Disorder

United States
Orexigen Therapeutics, Inc

Completed

Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity

Obesity

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Bupropion for Treating Nicotine Dependence in Young People

Tobacco Use Disorder | Tobacco Use Cessation

United States
Watching Over Mothers & Babies Foundation
University of Arizona

Completed

Bupropion for Smoking Cessation in Pregnancy

Smoking Cessation | Pregnancy

United States
National Institute on Drug Abuse (NIDA)

Completed

Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia

Schizophrenia | Tobacco Use Disorder

United States
James Davis
Axsome Therapeutics, Inc.

Completed

AXS-05 Phase II Trial on Smoking Behavior

Smoking Cessation | Nicotine Dependence | Smoking, Cigarette

United States
Orexigen Therapeutics, Inc

Completed

Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers

Healthy

United States
Orexigen Therapeutics, Inc

Completed

A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

Obesity | Overweight

United States
Mayo Clinic
National Cancer Institute (NCI); University of Minnesota

Completed

Varenicline and Bupropion for Smoking Cessation (CHANBAN)

Smoking

United States
GlaxoSmithKline

Completed

Carcinogenicity Study of Bupropion

Depressive Disorder | Cancer
University of Rochester NCORP Research Base
National Cancer Institute (NCI)

Recruiting

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Be Diagnosed With Cancer and Have Completed Systemic Therapy

United States
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR)

Completed

Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers

Nicotine Dependence | Tobacco Dependence

Canada
Massachusetts General Hospital
Robert Wood Johnson Foundation

Terminated

Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-breastfeeding Women

Tobacco Use Disorder

United States
Sandoz

Completed

A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting Conditions

Depression
Massachusetts General Hospital

Completed

Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults

Attention Deficit Hyperactivity Disorder (ADHD) | Substance Use Disorder (SUD)
Massachusetts General Hospital

Terminated

Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder

Depression | Bipolar Disorder

United States
University of Arizona

Completed

Bupropion Treatment for Youth Smoking Cessation

Nicotine Dependence

United States
University of Maryland, Baltimore
US Department of Veterans Affairs

Completed

A Comparison of Bupropion SR and Placebo for Smoking Cessation

Tobacco Use Disorder

United States
North Dakota State University
Neuropsychiatric Research Institute, Fargo, North Dakota

Completed

A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery

Roux en Y Gastric Bypass

United States
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline

Completed

Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease

Myocardial Infarction | Smoking | Cardiovascular Disease | Unstable Angina

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

Combined Pharmaco/Behavior Therapy in Adolescent Smokers

Nicotine Dependence | Nicotine Use Disorder

United States
Eva Szigethy
Crohn's and Colitis Foundation

Completed

Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease

Fatigue | Sleep Disturbance | Inflammatory Bowel Disease

United States
The University of Texas Health Science Center,...
M.D. Anderson Cancer Center; The Center for Clinical and Translational Sciences... and other collaborators

Completed

Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy

Smoking Cessation

United States
GlaxoSmithKline

Completed

Bupropion and Specific Cardiovascular Malformations

Depressive Disorder | Smoking Cessation | Pregnancy
University of Nebraska

Completed

Bupropion in the Treatment of Methamphetamine Dependence

Methamphetamine Use Disorder

United States
Axsome Therapeutics, Inc.

Enrolling by invitation

An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients (TARGET)

Major Depressive Disorder | Treatment Resistant Depression

United States
Mayo Clinic
West Virginia University

Completed

Bupropion SR for Treating Smokeless Tobacco Use

Smokeless Tobacco

United States
Orexigen Therapeutics, Inc

Completed

A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression

Depression

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial

Cigarette Smoking-Related Carcinoma

United States
The University of Texas Medical Branch, Galveston
National Institute on Drug Abuse (NIDA); UConn Health

Completed

Bupropion for Smoking Cessation During Pregnancy

Tobacco Use Disorder | Pregnancy Related

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); GlaxoSmithKline

Completed

Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)

Depression | HIV Infections

United States
Massachusetts General Hospital

Terminated

Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia

Schizophrenia | Nicotine Dependence

United States
Orexigen Therapeutics, Inc

Completed

A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects

Obesity | Overweight

United States
Orexigen Therapeutics, Inc

Completed

A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent

Obesity | Overweight | Nicotine Dependence

United States
Pfizer

Completed

A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections

Acute Otitis Media

United States, Costa Rica, Chile, Guatemala, Slovakia, Estonia, Mexico, Russian Federation, Israel, Poland, Argentina, Dominican Republic, Panama
Orexigen Therapeutics, Inc

Completed

A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes

Obesity | Diabetes Mellitus, Type 2 | Overweight

United States
Duke University

Completed

Effect of Bupropion on Seizure Threshold in Depressed Patients

MDD

United States
Mayo Clinic

Completed

Chantix & Bupropion for Smoking Cessation (ChanBan)

Smoking | Tobacco Use Disorder

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA); Behavioral Health Services, Inc.

Completed

Pilot Trial of Bupropion Versus Placebo for Methamphetamine Abuse in Adolescents

Adolescent Methamphetamine Abuse

United States
University of Malaya

Completed

Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men

Sexual Dysfunctions, Psychological | Hypoactive Sexual Desire Disorder | Erectile Dysfunctions

Malaysia
Orexigen Therapeutics, Inc

Completed

A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program

Obesity | Overweight

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions

Healthy

United States
ZonMw: The Netherlands Organisation for Health...
GlaxoSmithKline; Pharmacia; The Netherlands Asthma Foundation

Completed

Smoking Cessation in Patients With COPD (SMOCC) in General Practice (SMOCC)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting Conditions

Healthy

United States
Orexigen Therapeutics, Inc

Completed

A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects

Obesity

United States
Orexigen Therapeutics, Inc

Completed

Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity

Obesity

United States
Orexigen Therapeutics, Inc

Completed

Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity

Obesity

United States
Thomas Jefferson University

Active, not recruiting

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

Head and Neck Squamous Cell Carcinoma | Lung Non-Small Cell Carcinoma

United States
National Institute on Drug Abuse (NIDA)

Completed

Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study

Methamphetamine Dependence

United States

Search clinical trials for: Augmenting: Antidepressant Bupropion-SR

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations